Human cytosolic sulfotransferase SULT1A1

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 4, 2007, Pages 685-689

  Hempel, Nadine ^a   Gamage, Niranjali ^b   Martin, Jennifer L ^b   McManus, Michael E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bioactivation; Human cytosolic sulfotransferase; p Nitrophenol; PAPS; Phase II metabolism; SULT1A1

Indexed keywords

ESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; SULFOTRANSFERASE; XENOBIOTIC AGENT;

CATALYSIS; CONJUGATION; CRYSTAL STRUCTURE; DNA ADDUCT; ENZYME REGULATION; ENZYME SPECIFICITY; HYDROPHILICITY; METABOLISM; SHORT SURVEY; SULFONATION;

ARYLSULFOTRANSFERASE; CATALYSIS; CYTOSOL; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 33847665560     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.10.002     Document Type: Short Survey

References (20)

1. Dalhoff K., Buus Jensen K., and Enghusen Poulsen H. Cancer and molecular biomarkers of phase 2. Methods in Enzymology 400 (2005) 618-627
2. Duanmu Z., Locke D., Smigelski J., Wu W., Dahn M.S., Falany C.N., et al. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metabolism and Disposition 30 (2002) 997-1004
3. Gamage N., Barnett A., Hempel N., Tresillian M., Latham C.F., Liyou N.E., et al. Human sulfotransferases and their role in chemical metabolism. Toxicological Sciences 90 (2006) 5-22
4. Gamage N.U., Duggleby R.G., Barnett A.C., McManus M.E., and Martin J.L. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. Journal of Biological Chemistry 278 (2003) 7655-7662
5. Gamage N.U., Tsvetanov S., Duggleby R.G., Duggleby R.G., Windmill K.F., Martin J.L., et al. The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. Journal of Biological Chemistry 280 (2005) 41482-41486
6. Glatt H., Boeing H., Engelke C.E., Ma L., Kuhlow A., Pabel U., et al. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutation Research 482 (2001) 27-40
7. Hempel N., Barnett A., Gamage N., McManus M.E., and Negishi M. Human SULT1A Sulfotransferases. In: Pacifici G.M., and Coughtrie M.W.H. (Eds). Human cytosolic sulfotransferases (2005), CRC Press, London 181-232
8. Hempel N., Wang H., LeCluyse E.L., Duggleby R.G., Windmill K.F., Martin J.L., et al. The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Molecular Pharmacology 66 (2004) 1690-1701
9. Kakuta Y., Petrotchenko E.V., Pedersen L.C., and Negishi M. The sulfuryl transfer mechanism; crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. Journal of Biological Chemistry 273 (1998) 27325-27330
10. Meinl W., Meerman J.H., and Glatt H. Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 12 (2002) 677-689
11. Ozawa S., Shimizu M., Katoh T., Miyajima A., Ohno Y., Matsumoto Y., et al. Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. Journal of Biochemistry (Tokyo) 126 (1999) 271-277
12. Pedersen L.C., Petrotchenko E., Shevtsov S., and Negishi M. Crystal structure of the human estrogen sulfotransferase-PAPS complex: Evidence for catalytic role of Ser137 in the sulfuryl transfer reaction. Journal of Biological Chemistry 277 (2002) 17928-17932
13. Raftogianis R.B., Wood T.C., Otterness D.M., van Loon J.A., and Weinshilboum R.M. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochemical and Biophysical Research Communications 239 (1997) 298-304
14. Strott C.A. Sulfonation and molecular action. Endocrine Reviews 23 (2002) 703-732
15. Sun X.F., Ahmadi A., Arbman G., Wallin A., Asklid D., and Zhang H. Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation to colorectal cancer risk and patients' survival. World Journal of Gastroenterology 11 (2005) 6875-6879
16. Veronese M.E., Burgess W., Zhu X., and McManus M.E. Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: Substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochemical Journal 302 (1994) 497-502
17. Wilborn T.W., Comer K.A., Dooley T.P., Reardon I.M., Heinrikson R.L., Falany C.N., et al. Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Molecular Pharmacology 43 (1993) 70-77
18. Wong C.F., Liyou N., Leggett B., Young J., Johnson A., and McManus M.E. Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clinical and Experimental Pharmacology and Physiology 29 (2002) 754-758
19. Wu M.T., Wang Y.T., Ho C.K., Wu D.C., Lee Y.C., Hsu H.K., et al. SULT1A1 polymorphism and esophageal cancer in males. International Journal of Cancer 103 (2003) 101-104
20. Zheng L., Wang Y., Schabath M.B., Grossman H.B., and Wu X. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: A case-control study. Cancer Letters 202 (2003) 61-69